Company Overview
GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.
Why Investors Should Care
Net profit has compounded at 18.8% per year over the last five years.
Carries low leverage with a debt-to-equity ratio of 0.12.
Recent Developments
- 5-Year Trend Long-term compounding — profit CAGR 18.8%.
Growth & Price Performance
Compounded Profit Growth
| 5 Years: | 18.77% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | +70.39% |
| 6 Months: | +50.23% |
| 3 Months: | -48.55% |
| 1 Month: | +16.79% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)42.57 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Profit CAGR of 18.8% over 5 years.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading 52.9% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Healthcare).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | GRDX GridAI Technologies Corp. PHARMA | 3.20 | -0.50 | $22.82M | 0.00% | -21.21% | -25.63% | - | 18.77% |
| 2 | LLY Eli Lilly and Company SPXR3KPHARMA | 1,123.91 | 37.80 | $1.00T | 0.60% | - | 102.29% | 7.20% | 11.41% |
| 3 | JNJ Johnson & Johnson SPXR3KPHARMA | 269.12 | 31.22 | $648.55B | 1.98% | 14.88% | 25.74% | 2.43% | 4.76% |
| 4 | ABBV AbbVie Inc. SPXR3KPHARMA | 248.78 | 70.48 | $439.62B | 2.78% | 10.47% | -129.24% | 1.75% | -29.06% |
| 5 | MRK Merck & Co., Inc. SPXR3KPHARMA | 148.46 | 118.77 | $366.28B | 2.31% | - | 6.96% | 5.64% | 10.01% |
| 6 | UNH UnitedHealth Group Incorporated SPXR3KPHARMA | 400.84 | 25.74 | $359.79B | 2.47% | 9.74% | 14.15% | 10.40% | 5.43% |
| 7 | NVS Novartis AG PHARMA | 137.70 | 20.80 | $261.73B | 3.36% | 21.09% | 30.35% | 9.25% | 26.22% |
| 8 | AZN AstraZeneca PLC NDXPHARMA | 160.04 | 23.99 | $248.20B | 2.00% | 15.97% | 21.96% | 9.82% | 45.96% |
| 9 | TMO Thermo Fisher Scientific Inc. SPXR3KPHARMA | 603.02 | 32.49 | $222.97B | 0.29% | 8.14% | 13.51% | 8.81% | 12.95% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 38.21K |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -613.74K |
| Operating Income | -1.41M | -1.35M | -1.72M | -2.19M | -2.81M | -2.38M | -2.73M | -3.58M | -3.26M | -2.57M | -4.60M | -4.93M | -4.08M | -2.93M | -2.39M | -3.71M | -8.21M | -9.28M | -30.40M | -9.38M | -5.41M | 4.39M | -4.06M | -4.18M | -3.43M | -9.10M | -3.43M | -1.89M | -821.39K | -638.86K | -934.79K | -3.61M |
| Net Income | -1.87M | -1.99M | -3.77M | -3.20M | -2.81M | -2.67M | -3.13M | -3.63M | -3.31M | -2.57M | -4.66M | -5.04M | -4.19M | -5.26M | -4.70M | -5.31M | -7.69M | -9.28M | -30.40M | -9.63M | -5.41M | 4.39M | -4.07M | -4.19M | -3.43M | 5.57M | -8.81M | -2.58M | -1.26M | -998.27K | -1.15M | - |
| Diluted EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -5.42 | -1.63 | -98.00 | -138.28 | -53.47 | 18.23 | -36.46 | -37.73 | -9.21 | 0.38 | -3.86 | -1.76 | -0.84 | -0.21 | -0.75 | -0.82 |
| R&D Expense | 364.00K | 685.58K | 840.66K | 744.31K | 534.14K | 743.42K | 966.68K | 1.68M | 925.78K | 1.17M | 3.01M | 2.88M | 2.22M | 1.55M | 1.09M | 1.80M | 2.52M | 5.65M | 3.05M | 4.98M | 2.91M | 791.07K | 1.36M | 1.35M | 1.01M | 554.66K | 219.59K | 207.00K | 15.83K | 10.63K | 6.67K | 631.38K |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | 0 | 0 | - | - | 0 | 0 | 0 | 36.25K |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | 0 | 693.68K |
| Gross Profit | - | - | - | - | - | - | - | - | - | 0 | -657.43K |
| Operating Expenses | - | - | - | - | - | - | - | 12.68M | 15.77M | 15.62M | 6.43M |
| Operating Income | -4.73M | -6.33M | -10.22M | -13.43M | -14.74M | -26.43M | - | -12.68M | -15.77M | -15.62M | -7.08M |
| EBITDA | - | - | - | - | - | - | - | -14.58M | -15.74M | -15.57M | -6.51M |
| Interest Expense | - | - | - | - | - | - | 11.23K | 15.88K | 22.46K | - | - |
| Pretax Income | - | - | - | - | - | - | - | -14.63M | -15.79M | -15.62M | -6.64M |
| Tax Provision | - | - | - | - | - | - | - | - | - | 0 | -398.74K |
| Net Income | -5.93M | -14.59M | -11.10M | -13.53M | -15.18M | -32.67M | - | -14.63M | -15.79M | -18.06M | -6.39M |
| Diluted EPS | - | - | - | - | - | -14.68 | - | -1,250.82 | -143.64 | -15.99 | -4.16 |
| R&D Expense | 1.40M | 2.50M | 2.40M | 5.77M | 8.68M | 5.89M | 16.99M | 8.78M | 5.03M | 903.94K | 925.48K |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Sep 2021 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 6.69M | 6.75M | 5.48M | 7.47M | 8.90M | 12.92M | - | 11.79M | 5.44M | 6.88M | 85.41M | 48.55M |
| Total Equity | 2.64M | -3.63M | 3.21M | 1.66M | 4.47M | 4.62M | -2.64M | 6.97M | -7.82M | 2.74M | 3.60M | -3.88M | 24.94M |
| Cash & Equivalents | - | - | - | - | - | - | 6.06M | - | 8.25M | 1.36M | 3.71M | 163.48K | 899.78K |
| Total Liabilities | - | 10.32M | 3.54M | 3.82M | 3.00M | 4.29M | 15.56M | - | 19.61M | 2.70M | 3.28M | 27.61M | 19.72M |
| Current Liabilities | - | 8.82M | 2.34M | 2.48M | 3.00M | 4.29M | 15.55M | - | 12.30M | 2.48M | 3.13M | 27.55M | 15.16M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -4.17M | -4.53M | -7.18M | -10.87M | -14.03M | -11.22M | -32.29M | -22.34M | -12.38M | -9.22M | -5.70M |
| Investing Cash Flow | -24.38K | -12.36K | -32.17K | -305.47K | -24.10K | 87.35K | -10.32M | - | -500.00K | 88.17K | 323.48K |
| Financing Cash Flow | 4.68M | 5.75M | 6.01M | 11.71M | 13.14M | 17.05M | 44.76M | 15.74M | 15.23M | 5.58M | 5.89M |
| Capital Expenditure | - | - | -32.17K | -55.47K | -24.10K | -4.17K | -69.49K | - | - | - | - |
| Free Cash Flow | - | - | -7.22M | -10.92M | -14.06M | -11.23M | -32.36M | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | -1,813.6% |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | -19,540.0% |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | -17,634.4% |
| ROE % | 163.4% | -454.1% | -668.2% | -302.5% | -328.7% | 1,237.2% | - | -533.5% | -438.4% | 465.8% | -25.6% |
| ROCE % | 222.0% | -143.3% | -340.6% | -300.2% | -319.3% | 1,008.3% | - | -428.9% | -420.6% | -27.0% | -21.2% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Renaissance Technologies, LLC | 2.47% | 176.30K | $548.29K |
| 2 | Citadel Advisors Llc | 1.20% | 85.33K | $265.36K |
| 3 | Federation Des Caisses Desjardins Du Quebec | 1.07% | 76.35K | $237.45K |
| 4 | Vanguard Capital Management LLC | 1.04% | 74.06K | $230.33K |
| 5 | Geode Capital Management, LLC | 0.84% | 59.90K | $186.28K |
| 6 | Jane Street Group, LLC | 0.69% | 49.24K | $153.12K |
| 7 | Vanguard Fiduciary Trust Co | 0.47% | 33.80K | $105.13K |
| 8 | State Street Corporation | 0.33% | 23.45K | $72.92K |
| 9 | HRT Financial LP | 0.29% | 20.96K | $65.19K |
| 10 | Independent Advisor Alliance | 0.21% | 15.00K | $46.65K |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for GRDX
GridAI Technologies Corp. (GRDX) uses Rule 12b-25 for brief Q2 10-Q delay - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxOZ2I2bUE1VmFOZXRHaTB3MDVuRDgzZkUxdHl4WUV5XzlEWUxMamo5bUZrT29yTEVQOU9ubEpvOFZOMENLNTQ5Zy1WblJNQ3BXWXdzaWFmcjBhTl9IVlg5bDRCVHhQRDBmZC1iTkJmMTFmUjd3Zmx2SFc3TF94VmEzbmZORDg1c3V4VHdZTD…
Enterprise value to EBIT forward of GridAI Technologies Corp. – NASDAQ:GRDX - tradingview.com
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxNMUxrRDhwSjE1bjRPYVFEXzBvN01sTElpSGZ3SHJNMGlPTjNSeVpXSE9mRDB4RTRyYWMyc1pBZUwyTzBnOWlsMHhwVGVVLXk3ZzdYOFVfNnpjcFhFeU5wdzRjYWl0TExKWEhHU3ZFMDBkdkhEb0h3TUR5TXhrYUF2aFZQY3ZFYWdwZVpJeH…
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTFBJQkhEb196am9TOEE2S0cwb2ZMYU0wNnV3MVd1QzJydVBoak53eFNtaV9RNW45OGRkUVdYajB3V0kyV2lNNTdUbnc0MFVNbUlK?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <fon…
GridAI Technologies Corp. (NASDAQ: GRDX) Stock Price, News & Analysis - kalkine.com.au
<a href="https://news.google.com/rss/articles/CBMiVkFVX3lxTE04WWdwSm95YVJsWDhBel9peXlBcFNDRzJBb2RqdWV0WFJBN2VTMVRGelBEWHJYQnZaczRGLUlKZlJZajBnbnRVWU54QnN4THg3RGpxSDdB?oc=5" target="_blank">GridAI Technologies Corp. (NASDAQ: GRDX) Stock Pric…
GRDX - Finviz
<a href="https://news.google.com/rss/articles/CBMiRkFVX3lxTE5uR1J5Y282Wk9kLXU0a3NDWS1WVjRxSGxpczNYbU9hdm9aaFl3bGQ0NFNaVEJfWnIzQ0lYS2YxQk55dEp6c2c?oc=5" target="_blank">GRDX</a> <font color="#6f6f6f">Finviz</font>…
GridAI Technologies Corp. (NASDAQ: GRDX) Stock Price, News & Analysis - kalkine.ca
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE9nSzRrLWR4eVhYbXBkVTNqT0VPcjZmRGo3OEt3cFVKYVpDLUtmcGtUd2Q5TEZjcExnck5lcHVHbF9JSFlSTF8wYjJIYzVGR09x?oc=5" target="_blank">GridAI Technologies Corp. (NASDAQ: GRDX) Stock Price, News …
GRDX — Frequently Asked Questions
What is the current share price of GridAI Technologies Corp. (GRDX)?
As of 2026-09-19 21:16 PDT, GridAI Technologies Corp. (GRDX) trades at $3.20 on NasdaqCM. Its 52-week range is $1.83 to $6.80.
What is the market capitalisation of GRDX?
GridAI Technologies Corp. (GRDX) has a market capitalisation of $22.82M on NasdaqCM.
What is the P/E ratio of GRDX?
GRDX trades at a trailing price-to-earnings (P/E) ratio of -0.50. The industry average P/E is 24.83.
What is the return on equity (ROE) of GRDX?
GRDX has a return on equity (ROE) of -25.63%. Its return on capital employed (ROCE) is -21.21%.
Is GRDX a good stock to buy?
This page provides a data-driven analysis of GridAI Technologies Corp. (GRDX), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.